Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Pradat

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
The Journal of Antimicrobial Chemotherapy|July 20, 2016
Maraviroc/raltegravir simplification strategy following 6 months of quadruple therapy with tenofovir/emtricitabine/maraviroc/raltegravir in treatment-naive HIV patientsPierre Pradat, Jacques Durant, Corinne Brochier, et al.
Harm Reduction Journal|October 16, 2023
Willingness to use a drug consumption room among people who use drugs in Lyon, France, a city with no open scene of drug use (the TRABOUL survey)Mathieu Chappuy, Philippe Lack, Baptiste David, et al.
Journal of Hepatology|April 6, 2013
Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver diseaseEric Trépo, Romy Ouziel, Pierre Pradat, et al.
BMC Cancer|August 25, 2018
Evaluation of postoperative ascites after somatostatin infusion following hepatectomy for hepatocellular carcinoma by laparotomy: a multicenter randomized double-blind controlled trial (SOMAPROTECT)Kayvan Mohkam, Michel Rayar, Jean-Philippe Adam, et al.
Sleep|September 10, 2025
Feasibility and efficacy of exercise training on sleep symptoms and comorbidities in narcolepsy type 1: a prospective interventional studyFrançois Ricordeau, Emeric Stauffer, Benjamin Putois, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 27, 2020
Evaluation of first-line therapies for the treatment of candidemia in ICU patients: A propensity score analysisAnne-Lise Bienvenu, Pierre Pradat, Claude Guerin, et al.
Therapeutic Drug Monitoring|August 26, 2016
Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon RibavirinVéronique Loustaud-Ratti, Marianne Maynard, Sylvie Thevenon, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 30, 2011
Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI studyJean Lacau St Guily, Anne-Carole Jacquard, Jean-Luc Prétet, et al.
Journal of Hepatology|December 15, 2010
Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver diseaseEric Trépo, Andrej Potthoff, Pierre Pradat, et al.
Iscience|August 14, 2023
Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosisYasmina Chouik, Fanny Lebossé, Marie-Laure Plissonnier, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
The Journal of Antimicrobial Chemotherapy|July 20, 2016
Maraviroc/raltegravir simplification strategy following 6 months of quadruple therapy with tenofovir/emtricitabine/maraviroc/raltegravir in treatment-naive HIV patientsPierre Pradat, Jacques Durant, Corinne Brochier, et al.
Harm Reduction Journal|October 16, 2023
Willingness to use a drug consumption room among people who use drugs in Lyon, France, a city with no open scene of drug use (the TRABOUL survey)Mathieu Chappuy, Philippe Lack, Baptiste David, et al.
Journal of Hepatology|April 6, 2013
Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver diseaseEric Trépo, Romy Ouziel, Pierre Pradat, et al.
BMC Cancer|August 25, 2018
Evaluation of postoperative ascites after somatostatin infusion following hepatectomy for hepatocellular carcinoma by laparotomy: a multicenter randomized double-blind controlled trial (SOMAPROTECT)Kayvan Mohkam, Michel Rayar, Jean-Philippe Adam, et al.
Sleep|September 10, 2025
Feasibility and efficacy of exercise training on sleep symptoms and comorbidities in narcolepsy type 1: a prospective interventional studyFrançois Ricordeau, Emeric Stauffer, Benjamin Putois, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 27, 2020
Evaluation of first-line therapies for the treatment of candidemia in ICU patients: A propensity score analysisAnne-Lise Bienvenu, Pierre Pradat, Claude Guerin, et al.
Therapeutic Drug Monitoring|August 26, 2016
Efficiency and Safety of an Early Dose Adjustment of Ribavirin in Patients Infected With Hepatitis C Underexposed to the Drug and Treated With Peginterferon RibavirinVéronique Loustaud-Ratti, Marianne Maynard, Sylvie Thevenon, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 30, 2011
Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI studyJean Lacau St Guily, Anne-Carole Jacquard, Jean-Luc Prétet, et al.
Journal of Hepatology|December 15, 2010
Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver diseaseEric Trépo, Andrej Potthoff, Pierre Pradat, et al.
Iscience|August 14, 2023
Circulating microRNAs improve bacterial infection diagnosis and overall survival prediction in acute decompensation of liver cirrhosisYasmina Chouik, Fanny Lebossé, Marie-Laure Plissonnier, et al.
Pageof 11